Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline/Creatine vs Celecoxib/Creatine in ALS
NCT00355576Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jul 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline, celecoxib in amyotrophic lateral sclerosis (ALS), sponsored by Columbia University. Started Jul 2006; status: completed.
02
Drugs
minocyclinecelecoxib
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00355576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355576.